← Open Payments lookup

NICHOLAS GOODWIN: Open Payments

NPI 1467948471 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,281 in 40 payments from 12 companies in 2025. Trend: 2023 $336 · 2024 $282 · 2025 $1,281

Food & beverage: $1,166Consulting: $115
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc10$423
Neurocrine BioSciences, Inc.4$156
Alkermes, Inc.6$120
Janssen Scientific Affairs, LLC1$115
Supernus Pharmaceuticals, Inc.3$115
Axsome Therapeutics, Inc.4$108
Lundbeck LLC4$74
Otsuka America Pharmaceutical, Inc.3$69
E.R. Squibb & Sons, L.L.C.2$42
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$23

Products named: SPRAVATO, INVEGA SUSTENNA, REXULTI, Qelbree, Auvelity, LYBALVI, INGREZZA, COBENFY.

Industry payments across WA — which companies pay providers there.